Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus

Fu,Jun; Xue,Rui; Gu,Junfeng; Xiao,Yun; Zhong,Heying; Pan,Xuelian; Ran,Ran

doi:10.3892/mmr.2013.1734

Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus

Authors:
- Jun Fu
- Rui Xue
- Junfeng Gu
- Yun Xiao
- Heying Zhong
- Xuelian Pan
- Ran Ran
View Affiliations

Affiliations: Department of Anesthesiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China
Published online on: October 14, 2013 https://doi.org/10.3892/mmr.2013.1734
Pages: 1708-1714

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Calcitriol has been demonstrated to provide neuroprotection against ischemia/reperfusion (I/R) injury. However, the exact mechanism of this protection remains unknown. In the present study, the neuroprotective effect of calcitriol was investigated in rats exposed to cerebral I/R injury induced by middle cerebral artery occlusion (MCAO). In addition, the involvement of NR3A, extracellular signal‑regulated kinase 1/2 (ERK1/2), and phosphorylated cAMP/Ca2+‑response element binding protein (p‑CREB) in this protective action was determined in the hippocampal neurons. Western blot analysis was conducted to analyze the protein levels of NR3A, mitogen‑activated protein kinase kinase (MEK) and p‑CREB. The immunoreactivity of p‑CREB and NR3A were measured by quantum dot‑based immunofluorescence analysis. Results showed that MCAO rats exhibited large cortical infarct volumes. By contrast, intraperitoneal administration of calcitriol significantly reduced infarct volumes seven days following reperfusion, and these results were accompanied by elevated NR3A and p‑CREB activity in the hippocampal neurons. The inhibition of MEK by the addition of PD98059 led to attenuation of the neuroprotective effects of calcitriol and a correlated decrease in CREB activity. The results also demonstrated that calcitriol protected the brain from I/R injury through the NR3A‑MEK/ERK‑CREB pathway.

View Figures

View References

1	Feigin VL: Stroke epidemiology in the developing world. Lancet. 365:2160–2161. 2005. View Article : Google Scholar : PubMed/NCBI
2	Fisher M, Feuerstein G, Howells DW, et al: Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 40:2244–2250. 2009. View Article : Google Scholar : PubMed/NCBI
3	Grotta JC, Burgin WS, El-Mitwalli A, et al: Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol. 58:2009–2013. 2001. View Article : Google Scholar : PubMed/NCBI
4	McBain CJ and Mayer ML: N-methyl-D-aspartic acid receptor structure and function. Physiol Rev. 74:723–760. 1994.PubMed/NCBI
5	Dingledine R, Borges K, Bowie D and Traynelis SF: The glutamate receptor ion channels. Pharmacol Rev. 51:7–61. 1999.
6	Sucher NJ, Akbarian S, Chi CL, et al: Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci. 15:6509–6520. 1995.PubMed/NCBI
7	Chatterton JE, Awobuluyi M, Premkumar LS, et al: Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415:793–798. 2002. View Article : Google Scholar : PubMed/NCBI
8	Das S, Sasaki YF, Rothe T, et al: Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature. 393:377–381. 1998. View Article : Google Scholar : PubMed/NCBI
9	Perez-Otano I, Schulteis CT, Contractor A, et al: Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci. 21:1228–1237. 2001.PubMed/NCBI
10	Sasaki YF, Rothe T, Premkumar LS, et al: Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol. 87:2052–2063. 2002.PubMed/NCBI
11	Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S and Sevarino KA: Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci. 15:6498–6508. 1995.PubMed/NCBI
12	DeLuca HF and Zierold C: Mechanisms and functions of vitamin D. Nutr Rev. 56:S4–S10, (discussion S54–S75). 1998. View Article : Google Scholar : PubMed/NCBI
13	Brown AJ, Dusso A and Slatopolsky E: Vitamin D. Am J Physiol. 277:F157–F175. 1999.PubMed/NCBI
14	Landfield PW and Cadwallader-Neal L: Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging. 19:469–477. 1998. View Article : Google Scholar : PubMed/NCBI
15	Wang Y, Chiang YH, Su TP, et al: Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 39:873–880. 2000. View Article : Google Scholar : PubMed/NCBI
16	Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW and Porter NM: Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci. 21:98–108. 2001.PubMed/NCBI
17	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
18	Kostandy BB: The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci. 33:223–237. 2012. View Article : Google Scholar : PubMed/NCBI
19	Szydlowska K and Tymianski M: Calcium, ischemia and excitotoxicity. Cell Calcium. 47:122–129. 2010. View Article : Google Scholar
20	Henson MA, Roberts AC, Pérez-Otaño I and Philpot BD: Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol. 91:23–37. 2010. View Article : Google Scholar : PubMed/NCBI
21	Shen H, Chen GJ, Harvey BK, Bickford PC and Wang Y: Inosine reduces ischemic brain injury in rats. Stroke. 36:654–659. 2005. View Article : Google Scholar : PubMed/NCBI
22	Shen H, Kuo CC, Chou J, et al: Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 23:1958–1968. 2009. View Article : Google Scholar : PubMed/NCBI
23	Hardingham GE, Fukunaga Y and Bading H: Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 5:405–414. 2002.PubMed/NCBI
24	Hoyte L, Barber PA, Buchan AM and Hill MD: The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med. 4:131–136. 2004. View Article : Google Scholar : PubMed/NCBI
25	Liu Y, Wong TP, Aarts M, et al: NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 27:2846–2857. 2007. View Article : Google Scholar : PubMed/NCBI
26	Terasaki Y, Sasaki T, Yagita Y, et al: Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J Cereb Blood Flow Metab. 30:1441–1449. 2010. View Article : Google Scholar : PubMed/NCBI
27	Cavara NA and Hollmann M: Shuffling the deck anew: how NR3 tweaks NMDA receptor function. Mol Neurobiol. 38:16–26. 2008. View Article : Google Scholar : PubMed/NCBI
28	Stys PK and Lipton SA: White matter NMDA receptors: an unexpected new therapeutic target? Trends Pharmacol Sci. 28:561–566. 2007. View Article : Google Scholar : PubMed/NCBI
29	Piña-Crespo JC, Talantova M, Micu I, et al: Excitatory glycine responses of CNS myelin mediated by NR1/NR3 ‘NMDA’ receptor subunits. J Neurosci. 30:11501–11505. 2010.PubMed/NCBI
30	Chatterton JE, Awobuluyi M, Premkumar LS, et al: Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415:793–798. 2002. View Article : Google Scholar : PubMed/NCBI
31	Fukumori R, Takarada T, Nakamichi N, et al: Requirement of both NR3A and NR3B subunits for dominant negative properties on Ca²⁺ mobilization mediated by acquired N-methyl-D-aspartate receptor channels into mitochondria. Neurochem Int. 57:730–737. 2010. View Article : Google Scholar : PubMed/NCBI
32	Nakanishi N, Tu S, Shin Y, et al: Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci. 29:5260–5265. 2009. View Article : Google Scholar : PubMed/NCBI
33	Zhu DY, Lau L, Liu SH, Wei JS and Lu YM: Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA. 101:9453–9457. 2004. View Article : Google Scholar : PubMed/NCBI
34	Walton MR and Dragunow I: Is CREB a key to neuronal survival? Trends Neurosci. 23:48–53. 2000. View Article : Google Scholar : PubMed/NCBI
35	Finkbeiner S: CREB couples neurotrophin signals to survival messages. Neuron. 25:11–14. 2000. View Article : Google Scholar : PubMed/NCBI